EGFR and hepatocellular carcinoma: Therefore, taking into consideration that both YAP and EGFR signaling play a vital role in the carcinogenesis of HCC, combined targeting the Hippo and EGFR signaling pathways might provide a novel therapeutic strategy for HCC treatment.